Leonid Timashev
Stock Analyst at DA Davidson
(0)
# 3774
Out of 5,287 analysts
72
Total ratings
40.00%
Success rate
-1.59%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Pyxis Oncology | Reiterates: Outperform | 8 8 | 1.2 | 566.67% | 6 | Mar 19, 2025 | |
Insmed | Reiterates: Outperform | 100 100 | 79.41 | 25.93% | 2 | Mar 19, 2025 | |
BRC | Maintains: Buy | 3 3 | 2.21 | 35.75% | 1 | Mar 19, 2025 | |
Alkermes | Initiates Coverage On: Sector Perform | 40 | 34.83 | 14.84% | 1 | Mar 13, 2025 | |
Edgewise Therapeutic... | Reiterates: Outperform | 56 56 | 23.4 | 139.32% | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 61 61 | 30.96 | 97.03% | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 143 192 | 129.35 | 48.43% | 8 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 40 40 | 23.95 | 67.01% | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Sector Perform | 70 70 | 62.8 | 11.46% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 18 18 | 3.1 | 480.65% | 4 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 80 82 | 46.59 | 76% | 2 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 86 86 | 36.34 | 136.65% | 12 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Sector Perform | 4 4 | 4.92 | -18.7% | 8 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sector Perform | 240 20 | n/a | n/a | 1 | Oct 18, 2022 |